Objectives/Hypothesis: High-mobility group box 1 (HMGB1) protein has been identified as a principal instigator of injury-induced inflammation in many organ systems. Physiologically, HMGB1 binds to chromatin in cell nucleus. Upon injury, cells release HMGB1 to extracellular milieu, triggering a destructive inflammatory response. Neutralizing or removing HMGB1 has been shown to control inflammation. Unfortunately, the role of HMGB1 in laryngeal inflammation and healing has yet to be defined. The purpose of this study was to determine spatial and temporal patterns of HMGB1 expression in surgically injured rat vocal folds up to 2 weeks after injury.
INTRODUCTION
Inflammation is an innate immune response to noxious stimuli. The classic immunology model of selfnonself discrimination stipulates that the immune system does not react against the self but reacts against the nonself or foreign agents such as pathogenic bacteria, viruses, and parasites. 1, 2 In the vocal folds, surgical trauma or phonotrauma is rarely associated with bacterial infections but rather is associated with mechanical injury. The ensuing scale of inflammation is important in mediating tissue-repair mechanisms that determine the final healing outcome. In the absence of foreign invaders as in infection-induced inflammation, the principle purveyor of the injury-induced inflammation is from endogenous products released by distressed cells or tissues. Such endogenous molecules are known as damage associated molecular pattern (DAMP) molecules or ''danger signals'' that instigate injury-induced inflammation and healing. 3, 4 Chromatin-associated protein high-mobility group box 1 (HMGB1) is one of the DAMP molecules released by injured cells upon mechanical challenge. [5] [6] [7] [8] [9] [10] [11] [12] HMGB1 is a 30kDa chromatin-binding protein that is ubiquitously expressed in normal cells. In physiologic conditions, HMGB1 is sequestered in cell nucleus to stabilize DNA structure 13 and thus is hidden from recognition by the immune system. Upon injury, however, necrotic cells release HMGB1 from the intracellular compartment to the extracellular milieu. When HMGB1 is exposed outside the cells, this protein becomes recognized by immune receptors and triggers various cellular responses pertinent to innate immunity and tissue repair. For example, immune receptors including toll-like receptor (TLR) 2, TLR4, and TLR9   14 are activated by HMGB1, resulting an induction of multiple proinflammatory cytokines, such as tumor necrosis factors (TNFs), 12, [15] [16] [17] [18] [19] [20] that sets the inflammation and healing process in motion.
The presence of HMGB1 has been well documented in various inflammatory diseases, such as arthritis and sepsis. 6, 14, 21 damage. 12 An anti-HMGB1 treatment of mice with liver necrosis ameliorated inflammatory cell recruitment. 22 Identifying HMGB1 in mechanically injured vocal folds is fundamental to understanding the mechanism by which the inflammatory and healing response is initiated and may suggest a potential therapeutic target for inflammation control to optimize vocal fold healing. Unfortunately, no investigation has documented the presence and functions of HMGB1 in the vocal folds. The primary goal of this study was to investigate whether HMGB1 was secreted to extracellular compartments that might function as ''danger signals'' in the vocal folds upon surgical injury. The precise spatial and temporal patterns of HMGB1 expression during vocal fold inflammation and healing were characterized using immunohistochemistry (IHC) and enzyme-linked immunosorbent protein assay (ELISA).
MATERIALS AND METHODS

Rat Vocal Fold Surgery
The current animal study was approved by the Institutional Animal Care and Use Committee of the University of Wisconsin-Madison (protocol MO2358). Eighty-four SpragueDawley male rats, 4 to 6 months old (450-500 g), were used in the study. Vocal fold injuries were created by following an established protocol. 23 Briefly, animals were anesthetized and their vocal folds were injured bilaterally using a 25-gauge needle to strip the vocal folds until the thyroarytenoid muscle was exposed. Fourteen rats with injured vocal folds were euthanized for laryngeal harvest at each of five postsurgery time points: 1 day, 3 days, 5 days, 1 week, and 4 weeks. An additional 14 animals had their larynges harvested as uninjured controls. Animals were euthanized via CO 2 asphyxiation. Immediately following euthanasia, total laryngectomy was performed. For each time point, two of the 14 larynges were fixed in formalin for histologic analysis. The remaining 12 larynges underwent microdissection procedures of vocal fold mucosa for protein analysis.
IHC of HMGB1 Localization
Formalin-fixed laryngeal specimens were embedded in paraffin and sectioned at 5 lm in the coronal plane. Only sections containing the midmembranous vocal folds were subjected to IHC staining for HMGB1. A primary rabbit polyclonal antibody against HMGB1 protein in 1:1,000 (Abcam, Cambridge, MA) and a secondary rabbit-on-rodent horseradish peroxidase micropolymer (Biocare Medical, Concord, CA) were used. Diaminobenzidine chromogen (BD Biosciences, San Jose, CA) was used to detect horseradish peroxidase before counterstaining with hematoxylin and mounting. Routine hematoxylin-and-eosin (H&E) staining was also performed to evaluate the overall vocal fold morphology over the time course. All stained sections were viewed with a Nikon E600 microscope (Nikon, Melville, NY) and were photographed using an Olympus DP71 microscope digital camera (Olympus, Tokyo, Japan). To evaluate whether the change of the HMGB1 expression was potentially due to the change of cell number in the wound site, cell counting was performed in this study. One representative H&E picture of each midmembranous vocal fold for each of the two animals at 200Â magnification was selected, and the number of cells in the lamina propria was counted by two independent, blinded raters and then averaged for analysis. Interrater reliability was at Pearson r ¼ 0.986 (P < .05).
Quantification of HMGB1 Proteins
Upon injury, HMGB1 proteins translocate from the cell nucleus to the cytoplasm and eventually to the extracellular milieu becoming ''danger signals.'' The presence of HMGB1 in the cytoplasmic compartment has been regarded as a characteristic marker for active secretion of HMGB1 to the extracellular milieu. 24 To evaluate the translocation process of HMGB1 in injured vocal folds, time-varying protein quantities in both nucleus and cytoplasmic compartments were tracked in the present study. For each larynx, both vocal fold mucosa were dissected from the thyroarytenoid muscle under a stereo-dissection microscope. Based on pilot data, four pairs of vocal folds were necessary to give one workable testing sample for downstream protein analysis. Therefore, per each time point, 12 pairs of vocal fold mucosa were dissected to give three workable testing samples for cytoplasmic-nuclear protein extractions.
To extract cytoplasmic and nuclear proteins, testing samples were homogenized on ice, lysed, and separated into nuclear and cytoplasmic fractions using the NE-PER nuclear and cytoplasmic extraction kit (Thermo Scientific, Rockford, IL) according to the manufacturer's instructions. The supernatant was collected and its protein concentration was measured using Micro BCA Protein Assay (Thermo Scientific, Rockford, IL) in duplicates. The Micro BCA data were used to normalized the downstream ELISA data for each corresponding sample.
HMGB1 ELISA kits (IBL International; Hamburg, Germany) were used to quantify HMGB1 proteins by following the manufacturer's instructions. Briefly, 100 lL of diluent buffer was added to each well. Then 10 lL of standards, positive control, and testing samples were added to each well and incubated for 24 hours at 37 C. Wells were washed five times with wash buffer and incubated for 2 hours at 25 C with 100 lL of peroxidase-conjugate solution to each well. Subsequently, wells were washed five times in wash buffer and incubated for 30 minutes at room temperature with 100 lL of color solution. Then 100 lL of stop solution was added to each well to stop the reaction. Wells were read at 450 nm on a FlexStation 3 microplate reader (Molecular Devices, Sunnyvale, CA). Experimental samples were run in triplicate.
Statistical Analysis
One-way analysis of variance was used to test the differences in cell numbers and ELISA HMGB1 expressions across time. If F tests revealed significant differences, post hoc pairwise comparisons using Fisher protected least squares difference were carried out. An a level of 0.05 was used for all comparisons. Unadjusted a levels were used because we opted to protect from Type II (b) error as well as Type I (a) error at this early stage of inquiry to predict the cell numbers and this novel protein expression in surgically injured vocal folds.
RESULTS
HMGB1 Spatial Localization in Injured Rat Vocal Folds
Uninjured vocal folds of control animals showed a strict nuclear localization of HMGB1 (Fig. 1A) . Starting at day 1 after surgery, injured vocal folds revealed nuclear-to-cytoplasmic redistribution of HMGB1 (Fig. 1C) as compared to uninjured controls (Fig. 1A) . Furthermore, massive cytoplasmic-to-extracellular deposition of HMGB1 was evident from day 3 through day 7 after surgery ( Fig. 1E,G,I ), concomitantly with massive cellular infiltration and disorganized neomatrix deposition (Fig. 1F,H,J) . At day 14, HMGB1 staining returned to a strict nuclear pattern as in the uninjured controls. Vocal fold re-epithelization was nearly completed and the neomatrix was relatively organized for day 14 animals (Fig. 1K,L) compared to those from earlier surgical time points.
Time-Varying Cell Numbers and HMGB1 Quantities in Injured Rat Vocal Folds
Compared to the uninjured controls, in injured rats, the cell numbers were significantly different overall (P .05) across time points. In injured rats, compared to uninjured controls, cell number increased significantly at 1 day (P ¼ .04), 5 days (P ¼ .01), and 7 days (P ¼ .04) after injury. In particular, cell number peaked at day 5. Cell numbers were not significantly different between the uninjured controls and day 14 animals (Fig. 2) .
Per the ELISA HMGB1 data, both nuclear and cytoplasmic HMGB1 showed significant overall differences (P .05) in expression across time points (Fig. 3) . In injured rats, compared to uninjured controls, expressions of nuclear and cytoplasmic HMGB1 did not change Representative immunohistochemical staining of HMGB1 of the same rats (600Â magnification) in corresponding H&E micrographs. HMGB1 is stained brown. Positive nuclear staining was evident in uninjured vocal folds. In addition to the nuclear expression, cytoplasmic (thin arrows) and extracellular (thick arrows) HMGB1 staining was evident in injured samples from day 1 to day 7 after surgery. On day 14, cytoplasmic and extracellular HMGB1 deposition became less evident.
significantly at 1 day after injury. However, significantly increases in nuclear and cytoplasmic HMGB1 expressions were observed at 5 days (P ¼ .02) and 3 days (P ¼ .01) postinjury time points, respectively. Both nuclear and cytoplasmic HMGB1 were not significantly different from their controls at 7-and 14-day time points.
DISCUSSION
This study is the first to characterize the spatial and temporal expression of HMGB1 in the laryngeal system. HMGB1 is a nuclear protein known to be ubiquitously expressed in mammalian cells. In the present study, HMGB1 was positively expressed in vocal fold cell nuclei from both normal and injured tissue specimens, suggesting that our detection method was sensitive for visualizing and quantifying HMGB1 at both physiologic and pathologic levels. In injured vocal fold tissue samples, a dynamic HMGB1 expression was observed both spatially and quantitatively. Translocation of HMGB1 from the cell nucleus to the cytoplasm was noted early in the course of events, that is, within the first 3 days after injury, suggesting the involvement of this protein in the early events of wound healing. The highest expression of cytoplasmic HMGB1 was found at 3 days after surgery, which coincided with the time window of active inflammation and extracellular deposition from the histologic observations. These results suggested that HMGB1 proteins were released to extracellular milieu to function as ''danger signals'' during inflammation following vocal fold surgery.
In addition to the HMGB1 expression, the timevarying cell numbers within lamina propria were examined. The temporal pattern of the cell number from the current study corroborated the findings of previous rat vocal fold reports. 25, 26 Furthermore, both nuclear HMGB1 level and cell count peaked at 5 days after injury. Peak expression of nuclear HMGB1 may be due to accumulation of HMGB1-nuclear-positive cells such as macrophages and fibroblasts in the wound site. On the other hand, the cytoplasmic HMGB1 level significantly increased and peaked at 3 days but then decreased significantly and returned to control levels at 5 days after injury onward. This temporal pattern of HMGB1 expression corroborated the literature regarding mice skinwound healing. 27 Our results suggested that nuclearcytoplasmic translocation of HMGB1 was active between 1 day and 3 days in postsurgical vocal fold tissues. In contrast to the results of nuclear HMGB1, the peak of cytoplasmic HMGB1 came before the peak of the cell number, suggesting that the increase of the cytoplasmic HMGB1 level was primarily caused by the nuclearcytoplasmic translocation process activated by tissue injury. A high level of cytoplasmic HMGB1 indicates an active inflammatory activity ongoing in the vocal fold mucosal tissue. We propose that cytoplasmic HMGB1 may be a novel marker of the inflammatory conditions in the vocal folds.
HMGB1 can act as an early trigger or a late modulator of inflammation depending on the stimuli. When tissue is first injured, HMGB1 is passively released from the nuclei of necrotic cells to the extracellular space. Secreted HMGB1 activates inflammatory cells, triggering a cascade of inflammatory responses. Besides responding to early tissue damage, HMGB1 is also actively released by native and infiltrating inflammatory cells in response to proinflammatory cytokines such as TNF-a and interleukin (IL) 1-b albeit with a delay of 9 to 16 hours in mice after lipopolysaccharide-induced lethal endotoxemia. 28 The secreted HMGB1 further stimulates the release of proinflammatory cytokines and HMGB1 of the same cells in an autocrine manner.
If vocal fold HMGB1 exhibits the aforesaid dual function that both instigates (an early trigger) and sustains (a late modulator) the inflammation process, the temporal pattern of cytoplasmic HMGB1 expression should be seen as bimodal in our data. The first peak of cytoplasmic HMGB1 was seen at 3 days after injury. However, the second peak of cytoplasmic HMGB1 expression was obscure in our data. A slight rebound of cytoplasmic HMGB1 level was observed at 7 days after injury; it was not statistically significant compared to the preceding day (5 day) and the uninjured controls. That said, comparing the current HMGB1 data with reported temporal profiles of vocal fold cytokines in the literature may provide insights of whether HMGB1 acted as an autocrine stimulus in vocal fold inflammation and healing. In previous rat vocal fold studies, 29, 30 mRNA expressions of both TNF-a and IL1-b were reported to be significantly increased at 1 hour, 4 hours, and 8 hours compared to the uninjured controls. Our 3-day peak of cytoplasmic HMGB1 may be the active response to TNF-a and IL1-b in addition to the injurious stimulus itself. At the same time, if secreted HMGB1 becomes an autocrine factor to stimulate the production of proinflammatory cytokines, upregulated mRNA expressions of TNF-a and IL1-b should also be seen around or after the 3-day time point. However, mRNA expressions of both TNF-a and IL1-b were not reported to be significantly different at 3 days following injury, 30 which was the furthest time point from injury for gene expression levels investigated in the literature. Changes in protein levels have been reported in the literature for later time points. In a rabbit vocal fold study, 31 the protein concentration of IL1-b peaked at day 1 and appeared to rebound at day 14. Our data also showed a similar rebound of cytoplasmic HMGB1 at 7 days after injury. Thus, if vocal fold HMGB1 acts as an autocrine stimulus to the release of proinflammatory cytokines, such action may take place between 7 and 14 days after injury.
The precise cell source of HMGB1 in injured vocal fold is unknown. Activated macrophages and fibroblasts have been documented as the primary cells to release HMGB1 in response to injury in other parts of the body. 12 Both cells were populated in native and injured vocal fold lamina propria. 25, 26, 32 However, macrophages were reported to be minimally migrated or proliferated in injured rat vocal folds, whereas fibroblasts were dominantly present over the time course of inflammation and healing. 26 Considering that fibroblasts are the primary cells in both native and injured vocal fold lamina propria, we propose that fibroblasts might be one of the primary cell sources in secreting HMGB1 to modulate inflammation and wound repair in the vocal fold microenvironment. Once the cellular origin of HMGB1 is confirmed, such cell types can be the targets for anti-HMGB1 treatments to attenuate inflammation and optimize healing following injury. Studies are in progress in our laboratory to define the cellular origins of HMGB1 in vocal fold tissue.
There is a limitation in this investigation that warrants discussion. The ELISA assay required at least 2.5 ng/mL protein extraction for valid quantification. Because of the size of the rat's vocal folds, tissue samples were pooled to provide sufficient protein qualities for downstream assaying. Four pairs of rat vocal folds were combined for each assay. Such tissue pooling reduced the sample size for each time point, limiting information on individual variation, and decreased statistical power.
CONCLUSION
In surgically injured vocal folds, the endogenous danger signal HMGB1 was translocated from the cell nuclei to the cytoplasm during the acute phase of wound healing. This dynamic HMGB1 expression indicates its potential role in inciting vocal fold inflammation and healing. Thus, HMGB1 may constitute a potential therapeutic target to control vocal fold inflammation following surgical trauma. Further work is currently being undertaken to identify the cell source of this important molecule and its roles in the induction and propagation of vocal fold inflammation.
